Abstract 1130: First-in-class KAT6A/KAT6B inhibitor CTx-648 (PF-9363) demonstrates potent anti-tumor activity in ER+ breast cancer with KAT6A dysregulation
| Image |  |
|---|---|
| Description | scientific article published in 2021 |
| Author/s |
author: Geoffrey J. Lindeman François Vaillant Jane Visvader |
| Publication date | July 1, 2021 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |